NCT01710761Unknown不适用
Effects of Neo40(TM) With Caffeine on Cycling Time Trial Performance
适应症
干预措施
试验速览
- 阶段
- 不适用
- 入组人数
- 16
- 试验地点
- 1
- 主要终点
- Improved Time Trial Performance
研究概览
简要总结
Acute supplementation of Neo40(TM), a nitrate lozenge, will improve cycling performance
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 21 Years 至 49 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Regular commuter cyclist or spin class participant
- •Male (VO2max < 50) or Female (VO2max < 45)
- •Blood pressure below 140/90
- •Non-smoker
排除标准
- •Does not cycle 2-3 times/week
- •Regular consumption of performance-enhancing substances
- •Type I or Type II diabetes
- •Renal, hepatic or cardiac disease
- •Current infectious disease
研究组 & 干预措施
Nitrate supplement with caffeine
Active Comparator
干预措施: Nitrate supplement with caffeine (Dietary Supplement)
Placebo
Placebo Comparator
干预措施: Placebo (Dietary Supplement)
结局指标
主要结局
Improved Time Trial Performance
时间窗: After 20 min steady-state cycling
Participants will cycle 20 min at increasing intensity: 8 min at 55% VO2max, 6 min at 65% VO2max, 6 min at 75% VO2max. The 20 km time trial consists of rolling hills.
次要结局
- Improved work efficiency(During 20 min steady-state cycling)
研究者
研究点 (1)
Loading locations...
相似试验
终止
2 期
A Study to Investigate the Effect of a Nitric Oxide Supplementation on Pre- and Mildly Hypertensive AdultsPre-hypertensionNCT02679248KGK Science Inc.67
已完成
2 期
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEFHeart FailureNCT02742129Adrian Hernandez105
已完成
2 期
Oral Nitrite for Older Heart Failure With Preserved Ejection FractionHeart FailureNCT02918552Gladwin, Mark, MD15
终止
不适用
Effects of Exercise and Improved Nitric Oxide Bioavailability on Arteriovenous Fistula MaturationEnd Stage Renal DiseaseNCT02164318Duke University11
已完成
2 期
Nitrite Supplementation in Long COVID PatientsCardiorespiratory FitnessLong COVIDNCT05618574VA Office of Research and Development17